Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?

Autor: Adriana Aparecida Durães Fonseca, Ana Carla Godinho Pinto, Thiago Portal da Paixão, Carlos Augusto Abreu Albério, José Luiz Fernandes Vieira

Publikováno v: Brazilian Journal of Infectious Diseases, Vol 24, Iss 4, Pp 352-355 (2020)

Rifampicin is a key component of treatment for tuberculosis and its efficacy is determined by the blood levels attained after therapeutic doses. However, there is a high variability of rifampicin blood levels that is related to both the patient and t

Externí odkaz: https://doaj.org/article/e8b23eaf09274cc8935f349fbc111b70

EP-323 - TROMBOCITOPENIA INDUZIDA POR ETAMBUTOL EM MENINGOENCEFALITE TUBERCULOSA: UM RELATO DE CASO

Autor: Ana Paula Figueiredo Silva, Marcos Vinicios Costa Coutinho, Rita Catarina Medeiros Sousa, Carlos Augusto Abreu Alberio, Julius Caesar Mendes Soares Monteiro

Publikováno v: Brazilian Journal of Infectious Diseases, Vol 28, Iss , Pp 104229- (2024)

Introdução: A tuberculose (TB) é causada por uma das 07 espécies do complexo Mycobacterium tuberculosis. O tratamento para adultos com TB meningoencefálica tem duração 12 meses, sendo o tratamento intensivo por 2 meses com rifampicina, isoniaz

Externí odkaz: https://doaj.org/article/19ef7136a6394d3e81af3be22b335349

Concentrations of rifampicin in pre-dose samples in patients with pulmonary tuberculosis

Autor: José Luiz Fernandes Vieira, Ana Carla Godinho Pinto, Breno Kristoffer Beleza Uchoa, Stefania de Medeiros Araujo Lucena, Carlos Augusto Abreu Albério

Publikováno v: Brazilian Journal of Infectious Diseases, Vol 23, Iss 2, Pp 130-133 (2019)
Brazilian Journal of Infectious Diseases, Volume: 23, Issue: 2, Pages: 130-133, Published: 18 JUL 2019

Rifampicin is used in both phases of treatment for tuberculosis. In chronic use, the short half-life and the self-induction of metabolism can decrease the levels of the drug below the minimal inhibitory concentration. The aim of the study was to inve

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b90bdb5501178a7d098a9e9420e4f2b4
http://www.sciencedirect.com/science/article/pii/S1413867019300686

Can diabetes mellitus modify the plasma concentrations of rifampicin in patients under treatment for tuberculosis?

Autor: José Luiz Fernandes Vieira, Carlos Augusto Abreu Albério, Adriana Aparecida Durães Fonseca, Thiago Portal da Paixão, Ana Carla Godinho Pinto

Publikováno v: Brazilian Journal of Infectious Diseases, Volume: 24, Issue: 4, Pages: 352-355, Published: 02 OCT 2020
Brazilian Journal of Infectious Diseases v.24 n.4 2020
Brazilian Journal of Infectious Diseases
Brazilian Society of Infectious Diseases (BSID)
instacron:BSID
Brazilian Journal of Infectious Diseases, Vol 24, Iss 4, Pp 352-355 (2020)

Rifampicin is a key component of treatment for tuberculosis and its efficacy is determined by the blood levels attained after therapeutic doses. However, there is a high variability of rifampicin blood levels that is related to both the patient and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4ae21447e00ac3b89390d9a0b8a9591e
https://pubmed.ncbi.nlm.nih.gov/32535111

Serum pyrazinamide concentrations in patients with pulmonary tuberculosis

Autor: Carlos Augusto Abreu Albério, Stefania de Medeiros Araujo Lucena, Ana Carla Godinho Pinto, José Luiz Fernandes Vieira

Publikováno v: Jornal Brasileiro de Pneumologia
Jornal Brasileiro de Pneumologia, Vol 45, Iss 2 (2019)
Jornal Brasileiro de Pneumologia, Volume: 45, Issue: 2, Article number: e20180254, Published: 18 APR 2019

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc85fc8c04f9e60bed6e53a439394d1f
http://europepmc.org/articles/PMC6733741